Lauren Merendino - Jan 18, 2023 Form 4 Insider Report for Myovant Sciences Ltd. (MYOV)

Role
Chief Commercial Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Stock symbol
MYOV
Transactions as of
Jan 18, 2023
Transactions value $
-$53,995
Form type
4
Date filed
1/20/2023, 03:34 PM
Previous filing
Oct 20, 2022
Next filing
Mar 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale -$54K -2.01K -1.17% $26.89 170K Jan 18, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.